Andrew Abrams

Andrew Abrams is a Partner in New Science Ventures, a venture capital firm focused on building companies that address large unmet needs in the Life Sciences and Information Technology sectors.

Prior to joining New Science Ventures, Andrew was an investment banker in JP Morgan’s healthcare practice where he focused on mergers and acquisitions and capital market transactions in Europe and the US. He supported a wide array of clients spanning the biotechnology, pharmaceutical, medical device and diagnostic sub-sectors.

Andrew holds BA and MSci degrees in Biochemistry from the University of Cambridge and holds an MBA from Harvard Business School.